Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Iatrogenic dependence, benzodiazepines/z-drugs/gabapentinoids Benzodiazepine misuse Benzodiazepines, z-drugs and gabapentinoids: dependence, withdrawal effects and discontinuation
Illicit drugs drug-induced excited state interactions with prescribed psychotropic drugs drugs of misuse summary
Iloperidone Antipsychotics - minimum effective doses Quick reference for licensed maximum doses Antidepressant-induced arrhythmia Equivalent doses Relative adverse effects - a rough guide
immediate-release (IR) preparations attention deficit hyperactivity disorder treatments modified release stimulant preparations preferred in adults medication doses for older adults
Impulsive behaviour, disinhibitory drug reactions, benzodiazepines
Incongruence of affect, multiple sclerosis
Inhaled administration acutely disturbed/violent patients antipsychotics
Initiation of risperidone ISM
Injectable diamorphine, prescribing guidelines for opioid dependency
In overdose
In pregnancy Drug choice in pregnancy neurodevelopment effects first-generation second-generation
Insomnia in pregnancy menopausal women melatonin use in children and adolescents people living with human immunodeficiency virus
Integrase strand transfer inhibitors, psychiatric adverse reactions
Interactions between illicit drugs and psychotropics
interferons-a and Ã, psychiatric adverse effects
Immediate release versus extended release
Inappropriate sexual behaviour in older people
Infant exposure
Initiation schedules
Injections
In-patient detoxification, alcohol withdrawal
Intentional non-adherence
Interactions with caffeine
international normalised ratio (INR), psychotropic agent effects
Interruptions in treatment
Interstitial nephritis
intracranial/intracerebral haemorrhage, SSRI risks
Intramuscular clozapine
Intranasal esketamine, treatment resistant depression Ketamine Official guidance on the treatment of depression Management of treatment-resistant depression - other well supported treatments
Intranasal naloxone